Evidence map›Paper›PMID 29405331›Full record

ArticleElectrophoresis2018

The analysis of alpha-1-antitrypsin glycosylation with direct LC-MS/MS.

Haidi Yin, Mingrui An, Pui-Kin So, Melody Yee-Man Wong, David M Lubman, Zhongping Yao

Abstract read
In one paragraph

Article in Electrophoresis, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. The role ofActa pharmaceutica Sinica. B · 2024
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 3 countries.

Haidi YinThe Hong Kong Polytechnic University Shenzhen Research Institute, Shenzhen, P. R. China.ORCID 0000-0002-1595-3950
Mingrui AnDepartment of Surgery, University of Michigan Medical Center, Ann Arbor, MI, USA.
Pui-Kin SoUniversity Research Facility in Life Sciences, The Hong Kong Polytechnic University, Kowloon, Hong Kong.
Melody Yee-Man WongUniversity Research Facility in Chemical and Environmental Analysis, The Hong Kong Polytechnic University, Kowloon, Hong Kong.
David M LubmanDepartment of Surgery, University of Michigan Medical Center, Ann Arbor, MI, USA.
Zhongping YaoDepartment of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Kowloon, Hong Kong.
Hong Kong Polytechnic University · HKUniversity of Michigan · US

Funding

Supplemental for Detection of Glycopeptides of MCI in Patient SerumR01CA160254 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI David M. Lubman · 2012 to 2026
$5.4M
NCI NIH HHS R01 CA160254NCI NIH HHS R01 CA160254 (D.M.L.)
6 · The paper itself

Abstract

A liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based methodology has been developed to differentiate core- and antennary-fucosylated glycosylation of glycopeptides. Both the glycosylation sites (heterogeneity) and multiple possible glycan occupancy at each site (microheterogeneity) can be resolved via intact glycopeptide analysis. The serum glycoprotein alpha-1-antitrypsin (A1AT) which contains both core- and antennary-fucosylated glycosites was used in this study. Sialidase was used to remove the sialic acids in order to simplify the glycosylation microheterogeneity and to enhance the MS signal of glycopeptides with similar glycan structures. β1-3,4 galactosidase was used to differentiate core- and antennary-fucosylation. In-source dissociation was found to severely affect the identification and quantification of glycopeptides with low abundance glycan modification. The settings of the mass spectrometer were therefore optimized to minimize the in-source dissociation. A three-step mass spectrometry fragmentation strategy was used for glycopeptide identification, facilitated by pGlyco software annotation and manual checking. The collision energy used for initial glycopeptide fragmentation was found to be crucial for improved detection of oxonium ions and better selection of Y1 ion (peptide+GlcNAc). Structural assignments revealed that all three glycosylation sites of A1AT glycopeptides contain complex N-glycan structures: site Asn70 contains biantennary glycans without fucosylation; site Asn107 contains bi-, tri- and tetra-antennary glycans with both core- and antennary-fucosylation; site Asn271 contains bi- and tri-antennary glycans with both core- and antennary-fucosylation. The relative intensity of core- and antennary-fucosylation on Asn107 was similar to that of the A1AT protein indicating that the glycosylation level of Asn107 is much larger than the other two sites.

Indexed as

alpha 1-AntitrypsinChromatography, High Pressure LiquidGlycopeptidesGlycoproteinsGlycosylationHumansPolysaccharidesProtein BindingProtein Structure, TertiaryTandem Mass Spectrometryalpha 1-AntitrypsinGlycopeptidesGlycoproteinsPolysaccharidesAlpha-1-antitrypsinFucosylationIn-source collision-induced dissociationMass spectrometry

Identifiers

PMID29405331
PMCPMC6077116
OpenAlexW2790239670

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.